(Q42628634)

4 November 2017

Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor (English)

1 reference

4 November 2017

4

1 reference

4 November 2017

5

David Julius

1 reference

4 November 2017

Seema Bhatnagar

1

1 reference

4 November 2017

Linda M Sun

series ordinal

2

1 reference

4 November 2017

Jacob Raber

series ordinal

3

1 reference

4 November 2017

Mary F Dallman

series ordinal

6

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

4 November 2017

Physiology & Behavior

1 reference

4 November 2017

81

1 reference

4 November 2017

4

1 reference

4 November 2017

545-555

1 reference

A new wave of serotonin receptors

4 November 2017

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Central monoamine and plasma corticosterone changes induced by a bacterial endotoxin: sensitization and cross-sensitization effects

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Suppression of restraint-induced plasma cytokines in mice pretreated with LPS.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Ethologically-based animal models of anxiety disorders

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Relationship between anxiety and serotonin in the ventral striatum

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Lateralization and catecholaminergic neuroimmunomodulation: prazosin, an alpha1/alpha2-adrenergic receptor antagonist, suppresses interleukin-1 and increases interleukin-10 production induced by lipopolysaccharides

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Role for serotonin3 receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

The mouse light/dark box test

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Contextual and auditory fear conditioning are mediated by the lateral, basal, and central amygdaloid nuclei in rats

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Nervous system distribution of the serotonin 5-HT3 receptor mRNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Effects of the IL-1 receptor antagonist on the IL-1- and endotoxin-induced activation of the HPA axis and cerebral biogenic amines in mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

The 5-HT3B subunit is a major determinant of serotonin-receptor function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Fear and anxiety: animal models and human cognitive psychophysiology

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Behavioral and physiological responses to stress are affected by high-fat feeding in male rats

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Pituitary-adrenal axis regulation in CRH-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PHYSBEH.2004.01.018

Identifiers

DOI

10.1016/J.PHYSBEH.2004.01.018

1 reference

4 November 2017

1 reference